|

DA-3501 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Dong-A ST Co., Ltd.1

Indications

  • Pancreatic Ductal Adenocarcinoma (mPDAC)1
  • GastroEsophageal Cancer1
  • Gastric (Stomach) Cancer1
  • Cancer1

Other1 trial

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.